Supply of Medicine and Medical / Surgical equipments : Adsorbed Diphtheria and Tetanus\nVaccine (DT) 10 dose vial\nAdsorbed Diphtheria and Tetanus\nVaccine(DT),10 dose vial. Adsorbed\nDiphtheria and Tetanus Vaccine BP or USP.\nEach 0.5ml single dose containing not less\nthan 30 international units (IU) of Diphtheria\nToxoid and not less than 40 IU of Tetanus\nToxoid.\ni.Offers should be only from vaccine\nsuppliers recommended by World Health\nOrganization (WHO) for bulk purchase for\nthe U.N. Agencies.\nii.The product should be from fresh stocks\nand each consignment should be prepared\npreferably from a single batch. Each batch\nshould accompany a certificate of analysis,\nlot release certificate issued by a laboratory\naccredited by National Control Authority and\nSummary Protocol of vaccine production\nand quality control test data should be\nsubmitted for protocol review.\niii.Each consignment should have a\nminimum remaining shelf life of 75% at the\ntime of receiving the consignment at MSD.\niv.The vaccine should also comply with the\ngeneral requirements for vaccines in the BP\nor USP.\nv.The vaccine should meet the most recent\nrequirements of WHO when tested by the\nmethods outlined by WHO.\nvi.Cold chain monitors or WHO\nrecommended other cold chain monitoring\ndevice should be included in each pack\nduring delivery and the cold chain should be\nmaintained during storage, transport and\ndelivery of vaccines.\nvii.The vaccine should be protected from\nlight and should be stored at a temperature\n+2'C to +8'C. Vaccines should not be frozen.\nviii.Each vial should be labeled accordingly\nindicating both date of manufacture and\nexpiry.\nix.Must be a WHO prequalified product.\nx.Each vial should contain a suitable vaccine\nvial monitor. etc .

STATE PHARMACEUTICALS CORPORATION OF SRI LANKA Sri Lanka has Released a tender for Supply of Medicine and Medical / Surgical equipments : Adsorbed Diphtheria and Tetanus\nVaccine (DT) 10 dose vial\nAdsorbed Diphtheria and Tetanus\nVaccine(DT),10 dose vial. Adsorbed\nDiphtheria and Tetanus Vaccine BP or USP.\nEach 0.5ml single dose containing not less\nthan 30 international units (IU) of Diphtheria\nToxoid and not less than 40 IU of Tetanus\nToxoid.\ni.Offers should be only from vaccine\nsuppliers recommended by World Health\nOrganization (WHO) for bulk purchase for\nthe U.N. Agencies.\nii.The product should be from fresh stocks\nand each consignment should be prepared\npreferably from a single batch. Each batch\nshould accompany a certificate of analysis,\nlot release certificate issued by a laboratory\naccredited by National Control Authority and\nSummary Protocol of vaccine production\nand quality control test data should be\nsubmitted for protocol review.\niii.Each consignment should have a\nminimum remaining shelf life of 75% at the\ntime of receiving the consignment at MSD.\niv.The vaccine should also comply with the\ngeneral requirements for vaccines in the BP\nor USP.\nv.The vaccine should meet the most recent\nrequirements of WHO when tested by the\nmethods outlined by WHO.\nvi.Cold chain monitors or WHO\nrecommended other cold chain monitoring\ndevice should be included in each pack\nduring delivery and the cold chain should be\nmaintained during storage, transport and\ndelivery of vaccines.\nvii.The vaccine should be protected from\nlight and should be stored at a temperature\n+2'C to +8'C. Vaccines should not be frozen.\nviii.Each vial should be labeled accordingly\nindicating both date of manufacture and\nexpiry.\nix.Must be a WHO prequalified product.\nx.Each vial should contain a suitable vaccine\nvial monitor. etc . in Pharmaceuticals. The tender was released on Mar 20, 2025.

Country - Sri Lanka

Summary - Supply of Medicine and Medical / Surgical equipments : Adsorbed Diphtheria and Tetanus\nVaccine (DT) 10 dose vial\nAdsorbed Diphtheria and Tetanus\nVaccine(DT),10 dose vial. Adsorbed\nDiphtheria and Tetanus Vaccine BP or USP.\nEach 0.5ml single dose containing not less\nthan 30 international units (IU) of Diphtheria\nToxoid and not less than 40 IU of Tetanus\nToxoid.\ni.Offers should be only from vaccine\nsuppliers recommended by World Health\nOrganization (WHO) for bulk purchase for\nthe U.N. Agencies.\nii.The product should be from fresh stocks\nand each consignment should be prepared\npreferably from a single batch. Each batch\nshould accompany a certificate of analysis,\nlot release certificate issued by a laboratory\naccredited by National Control Authority and\nSummary Protocol of vaccine production\nand quality control test data should be\nsubmitted for protocol review.\niii.Each consignment should have a\nminimum remaining shelf life of 75% at the\ntime of receiving the consignment at MSD.\niv.The vaccine should also comply with the\ngeneral requirements for vaccines in the BP\nor USP.\nv.The vaccine should meet the most recent\nrequirements of WHO when tested by the\nmethods outlined by WHO.\nvi.Cold chain monitors or WHO\nrecommended other cold chain monitoring\ndevice should be included in each pack\nduring delivery and the cold chain should be\nmaintained during storage, transport and\ndelivery of vaccines.\nvii.The vaccine should be protected from\nlight and should be stored at a temperature\n+2'C to +8'C. Vaccines should not be frozen.\nviii.Each vial should be labeled accordingly\nindicating both date of manufacture and\nexpiry.\nix.Must be a WHO prequalified product.\nx.Each vial should contain a suitable vaccine\nvial monitor. etc .

Deadline - Apr 30, 2025

MT reference number - 105339256

Product classification - Pharmaceutical products